Coronavirus Vaccine

Angela Eagle Excerpts

Wednesday 2nd December 2020 Commons Chamber

[Matt Hancock]

Yes, I absolutely will. I pay tribute to their work on preparing for the vaccine roll-out, and also their work in keeping the virus under control, which is such an important task, is so difficult, and has consumed so much effort this year, yet there is still more work to be done over this winter to get the vaccine rolled out.

[Ms Angela Eagle (Wallasey) (Lab)]

Two injections per person for everyone in the country is going to take an awful long time. The Prime Minister was hoping that it would be done by Easter. Does the Health Secretary share that timetable or will he publish another one? Is he planning on making this vaccine available again next year, since we do not know how long immunity lasts, and covid is likely to be endemic and with us for some time to come?

[Matt Hancock]

The hon. Lady asks two incredibly important questions, the first of which the hon. Member for Leicester South (Jonathan Ashworth) asked and I did not answer, for which I apologise. The speed at which we can continue this roll-out will be determined by the speed at which Pfizer can manufacture and whether the AstraZeneca Oxford vaccine, of which we have 100 million doses on order, is approved by the MHRA. I am afraid that I cannot answer the hon. Lady’s question on the timetable, or indeed the hon. Gentleman’s, because it is dependent on the approval of AstraZeneca and the manufacturing process of the Pfizer vaccine.

On the hon. Lady’s second question, I have completely forgotten what it was. [Hon. Members: “Next year.”] Next year, yes, and whether this vaccine is only short-term. One of the reasons we have 357 million doses from seven different vaccines is to be able to vaccinate with further doses if that is needed in due course, whether that is through re-procurement of one of the existing vaccines or by switching to a different vaccine if that is clinically appropriate. That is absolutely part of the potential future plans that we have under consideration, but it is too early to know the answer to that question as well.